Stay updated with breaking news from Mobile Opera. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
I often hear, “Hey, I know you from Twitter!” as I turn on my heels to identify the source. A variation of this exclamation has become commonplace at scientific conferences. Particularly in a time characterized by so much distance, the use of social media can be helpful for connecting with new areas of scholarship, fellow scientists and the people most affected by the work we do.
Although the development and use of biomarkers in liver transplantation has progressed in recent years, challenges and limitations remain, according to presenters at the American Transplant Congress 2022. Thomas D. Schiano, MD, professor of medicine and liver diseases at Mount Sinai in New York, told attendees that among transplant patients, biomarkers should monitor short- and long-term
Patients with psoriatic arthritis treated with bimekizumab demonstrated improvements across joint and skin parameters compared with placebo, according to Phase 3 clinical trial data presented at the EULAR 2022 Congress.“I am delighted to be able to present these very exciting Phase 3 data from the BE COMPLETE study of this inhibitor of both IL-17A and -F,” Joseph F. Merola, MD, of
The FDA has approved rituximab-arrx, in combination with methotrexate, in adult patients with moderate or severely active rheumatoid arthritis who have had inadequate responses to one or more TNF agonist therapies. Rituximab-arrx (Riabni, Amgen), a biosimilar to rituximab (Rituxan, Genentech) was previously approved for indications including non-Hodgkin’s lymphoma, chronic lymphocytic
Compared with living donors aged 50 to 70 years, donor age older than 70 years may be a negative predictor of kidney transplant and graft survival, according to a presentation at the American Transplant Congress.“I set out to see if the data and outcomes of a national cohort met my anecdotal findings that living kidney donor transplants from donors [older than] 70 years don’t perform